FDA NDC Directory · JSON-LD · Markdown

DOXIL

NDC 0338-0067 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION, LIPOSOMAL

Generic namedoxorubicin hydrochloride
Labeler / ManufacturerBaxter Healthcare Company
Marketing categoryNew Drug Application (innovator) · App NDA050718
Dosage form / routeINJECTION, SUSPENSION, LIPOSOMAL · INTRAVITREAL
Active ingredientsDOXORUBICIN HYDROCHLORIDE (2 mg/mL)
Marketing started20190813
Package count1

External sources

Source: openFDA. Public-domain (CC0).